Trial 2 - Performance in Delivering Clinical Research Q4 2015/16 – Name of Research Target Date agreed Trial Target Comments Ethics Number of to recruit Status Met Committee Patients target Reference number of Number patients An exploratory, 12 week, randomised, partially double-blinded, 14/EM/0101 No target N/A Closed N/A NCH&C is only – parallel trial to explore the effects of once daily needed in involved in delivering treatments of orally inhaled tiotropium + olodaterol fixed dose part of the combination or tiotropium (both delivered by the Respimat® inhaler), (at intervention and it is supervised exercise training and behaviour modification on exercise NNUH) not involved in capacity and physical activity in patients with Chronic Obstructive recruitment Pulmonary Disease (COPD) [PHYSACTO(TM)]
2 - Performance in Delivering Clinical Research – Q4 2015/16 Name of Trial Research Ethics Committee Reference Number Target Number of Patients Date agreed to recruit target number of patients Trial Status Target Met Comments An exploratory, 12 week, randomised, partially double-blinded, parallel trial to explore the effects of once daily treatments of orally inhaled tiotropium + olodaterol fixed dose combination or tiotropium (both delivered by the Respimat® inhaler), supervised exercise training and behaviour modification on exercise capacity and physical activity in patients with Chronic Obstructive Pulmonary Disease (COPD) [PHYSACTO(TM)] 14/EM/0101 No target needed N/A Closed – in (at NNUH) N/A NCH&C is only involved in delivering part of the intervention and it is not involved in recruitment
NCHandC%20Q4%20201516%20word%20doc%20for%20website.docx